Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fluidigm Corporation (NQ: FLDM )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fluidigm Corporation

Why SomaLogic Stock Dived by 10% on Wednesday
The market wasn't impressed by the company's announced tie-up with Standard BioTools. 
Via The Motley Fool
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
Unusual Options Activity Insight: Fluidigm
Shares of Fluidigm (NASDAQ:FLDM) saw some unusual options ... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
52 Biggest Movers From Friday
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:... 
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... 
Via Benzinga
Casdin Capital, Viking Global Investors Inject $250M In Fluidigm
Fluidigm Corporation (NASDAQ: FLDM) has approved a $250 million investment by Casdin Capital LLC and Viking Global Investors LP with zero-coupon... 
Via Benzinga
Fluidigm Shares Gain As Preliminary Q4, FY21 Sales Exceed Expectations
Fluidigm Corp (NASDAQ: FLDM) expects Q4 FY21 sales of $38.0 million - $38.3 million, exceeding the company's prior guidance of $31 million – $34 million... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat
Fluidigm Corp (NASDAQ: FLDM) posted Q3 revenues of $28.5 million, down 29% Y/Y, missing the consensus of $30.00 million, citing supply chain issues affecting product... 
Via Benzinga
Exposures COVID-19
Return on Capital Employed Insights for Fluidigm
After pulling data from Benzinga Pro it seems like during Q2, Fluidigm's (NASDAQ:FLDM) reported sales totaled $31.02 million. Despite a 10.62% in earnings, the company posted a... 
Via Benzinga
Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 Products
Fluidigm Corp's (NASDAQ: FLDM) second-quarter revenues grew 19% Y/Y to $31 million, edging out analysts' average expectation of $30.57 million. Base product and... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Sensus Healthcare (NASDAQ:SRTS) ... 
Via Benzinga
Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale
Fluidigm Corp (NASDAQ: FLDM) stock is trading higher in the premarket on a report that the Company is considering a sale. According to a Bloomberg report, the medical... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Applied DNA Sciences (NASDAQ:APDN) shares rose 27.71% to $7.42 during Tuesday's regular session. Trading volume for Applied DNA Sciences's stock is 7.2... 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... 
Via Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) surged 52.6% to $14.76 after dropping 11% on Monday. 3D Systems Corporation (NYSE: DDD) shares climbed 22.9% to $21.83 after... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers Bridgford Foods Corporation (NASDAQ: BRID) shares surged 46.2% to close at $20.74 on Tuesday. Sequential Brands Group, Inc. (NASDAQ: SQBG) shares jumped 36.5% to close at... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Assertio Holdings (NASDAQ:ASRT) shares moved upwards by 32.42% to $0.66 during Friday's pre-market session. The company's market cap stands at $114.5... 
Via Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
Fluidigm: Q1 Earnings Insights
Shares of Fluidigm (NASDAQ:FLDM) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 15.38% year over year to ($0.15... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers T2 Biosystems (NASDAQ:TTOO) share... 
Via Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.